98%
921
2 minutes
20
Background: Most of sudden cardiac death in the adult population is caused by ventricular fibrillation (VF) in the setting of acute myocardial ischemia. The assessment of risk factors for VF in this setting may point to novel causal pathways or new targets for intervention and risk prediction of sudden cardiac death.
Objective: This study aimed to evaluate the effect of family history of sudden death (SD), history of atrial fibrillation (AF), and anterior infarct location on the electrocardiogram on the development of VF during the first ST-elevation myocardial infarction (STEMI).
Methods: We performed an individual participant data meta-analysis of 3 European case-control studies including patients with a first STEMI (aged 18-80 years) with VF (cases) or without VF (controls) before revascularization.
Results: We included 1807 cases and 2923 controls (median age 59 years, 20% women) in the analyses. After adjusting for potential confounding, we found an independent association between the 3 risk factors and VF: family history of SD (odds ratio [OR] 1.61, 95% confidence interval 1.38-1.87), previous AF (OR 1.95, 1.22-3.11), and anterior myocardial infarction (OR 1.55, 1.36-1.75). Further investigation indicated increased effect of family history with multiple SDs in the family, a stronger effect of AF on VF developing within the first minutes of symptoms, and the effect of anterior infarctions being modified by enzymatically determined infarct size.
Conclusion: Family history of SD, history of AF, and anterior infarct location were all independently and additively associated with an increased risk of VF in patients with a first STEMI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hrthm.2025.06.026 | DOI Listing |
Cell Mol Biol (Noisy-le-grand)
September 2025
Department of Biology, College of Education for Pure Sciences, University of Kerbala, Kerbala, Iraq.
Gastric cancer is one of the causes of deaths related to cancer across the globe and both genetic and environmental factors are the most prominent. Causes of its pathogenesis. This paper researches the expression of the C-FOS gene.
View Article and Find Full Text PDFA 52-year-old Myanmar man presented with bilateral progressive painless asymmetrical wrist and finger drop in 1 year without any sensory and sphincter problems. He has hypochromic microcytic anemia diagnosed as Hemoglobin E disease before. However, a serial full blood count revealed thrombocytopenia and a drop in hemoglobin disproportionate to HbE disease.
View Article and Find Full Text PDFLead poisoning is rare, but easily missed, with the highest burden of disease occurring in low-to-middle income countries. However, when diagnosed, appropriate treatment can prevent long-term morbidity. A case is presented, reinforcing the importance of thorough history-taking and international guidelines in successful treatment.
View Article and Find Full Text PDFCase Rep Hematol
August 2025
Central Diagnostic Laboratories, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Factor XIII (FXIII) deficiency is a rare coagulopathy with an estimated prevalence of approximately 1 in 1 to 2 million, affecting males and females with equal frequency. FXIII plays a critical role in hemostasis by stabilizing fibrin clots through covalent cross-linking of fibrin monomers, thereby conferring mechanical resistance and durability to the clot structure. Clinically, FXIII deficiency presents with a spectrum of hemorrhagic manifestations including bleeding from the umbilical cord, intracranial hemorrhage, recurrent miscarriages, menorrhagia, epistaxis, gingival bleeding, and poor wound healing.
View Article and Find Full Text PDFCase Rep Hematol
August 2025
Department of Internal Medicine, Skagit Regional Health, Mount Vernon, Washington, USA.
Waldenström macroglobulinemia (WM) and essential thrombocythemia (ET) are distinct hematologic malignancies that have only been reported to co-occur in one previous patient. We present a 64-year-old man with a significant family history for WM who was found to have both ET and WM. He had symptomatic ET, diagnosed by elevated platelets and a positive JAK2 V617F mutation, and asymptomatic WM was found on serum electrophoresis done for screening due to family history.
View Article and Find Full Text PDF